U.S. General Merchandise and Department Stores Stock News

Clearway Energy has delivered a 56.6% total return over the past 5 years, yet its current checks still lean on the cheap side, which raises the question of whether the recent share price around US$33.77 is fully reflecting the underlying cash generation and risks. A 56.6% return over 5 years suggests Clearway Energy has already rewarded patient investors, so any further upside may depend on how much value is still not priced in. The build out of renewable and storage assets tied to long term...

Enphase Energy stock is caught between mixed valuation signals, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium to today’s price while market based multiples screen as more supportive, all against a five year share price record that has been heavily negative. Over the last 5 years, Enphase Energy has delivered a share price decline of 77.0%, which sets a cautious backdrop for any valuation case today. On the upside, new products such as the IQ9N...

In July 2026, Arovella Therapeutics announced a collaboration under which Charles River Laboratories International will provide GMP Next Generation Sequencing services for iNKT cell characterization and viral safety testing to support ALA-101, an off-the-shelf CAR-iNKT therapy targeting CD19+ B cell cancers. This partnership, combined with Charles River’s recent acquisition of NGS specialist Pathoquest, underscores its push into higher-value sequencing-based testing for cell and gene...

ASP Isotopes Inc. recently filed a shelf registration statement to issue up to US$106.08 million of common stock, covering 23,160,682 shares. This sizeable shelf registration gives the company flexibility to access equity capital quickly, which could shape how investors view its future financing plans. We will now examine how this sizeable shelf registration shapes ASP Isotopes' investment narrative and what it may imply for future capital needs. The future of work is here. Discover the 32...

Cybin, operating as Helus Pharma, has advanced its lead psychedelic candidate HLP003 into an ongoing Phase 3 trial for adjunctive treatment of major depressive disorder and recently raised about US$50,000,000 in an underwritten public offering to support its development programs. This combination of late-stage clinical progress and fresh funding highlights how Cybin is positioning HLP003 within the evolving landscape of interventional psychiatry for depression care. We’ll now explore how the...

Etsy stock has staged a sharp recovery in the last year, yet its longer term shareholders are still sitting on a steep decline, and the valuation checks are sending mixed messages as the Discounted Cash Flow (DCF) intrinsic value estimate points to a discount while earnings based multiples lean expensive. Over 5 years, Etsy shares have declined 58.6%, which frames the current price against a much weaker long term return profile for existing holders. The approved sale of Depop to eBay for...

Cintas (CTAS) has wrapped up FY 2026 with fourth quarter revenue of US$2.9 billion and basic EPS of US$1.28, supported by trailing 12 month revenue of US$11.3 billion and basic EPS of US$4.98 that reflects earnings growth of about 10.7% over the past year. Over recent periods, the company has seen quarterly revenue move from US$2.67 billion in Q4 FY 2025 to US$2.91 billion in Q4 FY 2026, while basic EPS rose from US$1.11 to US$1.28. Those top line and per share gains are backed by a modest...

PFAS Funding Support Puts Essential Utilities in Focus Aqua Pennsylvania, a subsidiary of Essential Utilities (WTRG), recently secured $74.3 million in principal forgiveness and low-interest loans from PENNVEST to fund PFAS treatment projects across its service territory. This funding backs a planned PFAS treatment system at the Neshaminy Water Treatment Plant, serving about 62,000 customers, and additional installations at community well sites in Chester and Luzerne Counties, bringing...

Agenus recently announced an oversubscribed private placement of up to US$340 million, including a US$85,000,000 Regulation D securities purchase agreement with institutional investors such as Commodore Capital, RA Capital Management, TCGX, Invus, and Ligand Pharmaceuticals, alongside board expansion to add two Commodore-designated directors.

COMPASS Pathways (NasdaqGS:CMPS) is back in focus after reporting 26 week Phase 3 COMP006 data for its COMP360 psilocybin candidate in treatment resistant depression, alongside supportive regulatory progress and new PTSD analysis. See our latest analysis for COMPASS Pathways. Despite the latest positive trial readout, COMPASS Pathways' share price has been volatile, with a 1 day share price return that declined 6.61% and a 7 day share price return that declined 8.60%. However, the 90 day...

Why Albemarle Stock Is Back on Investors' Radar Upward revisions to earnings estimates and a recent upgrade to a buy rating have pushed Albemarle (ALB) into the spotlight, drawing more investor attention as expectations for this quarter's results gain traction. See our latest analysis for Albemarle. Despite the more positive earnings outlook, Albemarle's recent share price performance has been weak. The stock closed at US$119.46 and recorded a 30 day share price return that is down 28.08%...

Caris Life Sciences has had a difficult year for shareholders, with the stock down 47.3% over the past 12 months, yet its valuation checks still lean toward the shares looking cheap rather than expensive. With fresh product news in precision oncology and multi cancer screening, the question is whether the market is being too cautious or the valuation score is missing important risks. Over the last year, Caris Life Sciences has declined 47.3%, which suggests sentiment around the stock has...

SPX Technologies (SPXC) reported Q1 revenues that were 17.4% higher year on year, beating analyst expectations on both sales and EBITDA, and raised full year revenue guidance relative to sector peers, drawing fresh attention to the stock. See our latest analysis for SPX Technologies. Despite the strong Q1 update, SPX Technologies’ recent momentum has cooled, with the share price down 8.02% over the past 30 days and 3.38% over 90 days, even as the year-to-date share price return is 6.25% and...

Rocket Lab (NasdaqGS:RKLB) completed a full duration hot fire test of Neutron’s vacuum optimized AVac engine. The test represents a key technical step ahead of Neutron’s planned maiden flight as a medium lift, reusable rocket. This milestone focuses on hardware progress for Neutron, separate from recent attention on the VICTUS HAZE mission and the Iridium acquisition. For investors watching Rocket Lab, Neutron is the project that could move the company beyond its small satellite launch...

Coupang stock has fallen about 56% over the past five years, yet its current valuation checks lean cheap. This sets up a clear question for investors about whether the market is being too harsh or the risks are simply catching up with the share price. The share price decline of roughly 56% over five years suggests long term holders have faced heavy losses and the market has repeatedly reassessed what Coupang is worth. On the one hand, Coupang's push into new offerings and markets can support...

Recent attention on Northwest Bancshares (NWBI) has been driven by Northwest Bank’s inclusion in TIME’s America’s Best Companies 2026 list, as well as the creation of three senior roles focused on customer and marketing analytics. See our latest analysis for Northwest Bancshares. At a share price of $15.67, Northwest Bancshares has seen firm positive momentum, with a 30.80% year to date share price return and a 24.79% total shareholder return over the past year. This suggests that recent...

In July 2026, BlackSky Technology Inc. announced it had secured multiple U.S. R&D contracts to advance Gen-3 AI solutions for real-time, space-based tactical intelligence, surveillance and reconnaissance, including maturing automated target recognition within classified customer workflows. A distinctive aspect of these awards is BlackSky’s continued development of AI-enabled Battle Damage Detection analytics on its commercial Gen-3 platform, leveraging 35-centimeter resolution imagery to...

On June 25, CTS Corporation announced that Chief Operating Officer Pratik Trivedi was promoted to Chief Executive Officer and President effective July 6, with long-time CEO Kieran O'Sullivan moving to the role of Executive Chair, and the company also narrowed its fiscal 2026 revenue guidance to reflect increased confidence in its outlook. This combination of an internally promoted leader and a tighter revenue range signals a board keen to balance continuity with clearer expectations for...

Four Corners Property Trust (FCPT) recently closed a US$268.0 million purchase of 102 Mission Pet Health veterinary properties, a transaction that increased its year-to-date acquisitions to a record 139 properties. See our latest analysis for Four Corners Property Trust. The latest acquisition news comes alongside a period of positive momentum for Four Corners Property Trust. The share price is at US$26.42 after a 1-day share price return of 4.76% and a year-to-date share price return of...

3M (NYSE:MMM) and Microsoft announced a partnership to deploy 3M's Expanded Beam Optical technology in Microsoft Azure data centers. The collaboration focuses on data center connectivity for AI workloads and broader enterprise digital transformation at 3M. The agreement includes joint innovation plans that may influence both companies' roles in cloud and AI supply chains. For investors watching how industrial companies plug into the AI and cloud build out, this move puts 3M directly inside...

Integra LifeSciences Holdings recently touched a 52-week high on the back of a strong track record of positive earnings surprises and favorable analyst assessments, including a supportive Zacks Rank and Style Scores. An interesting angle for investors is how the company’s consistent earnings outperformance and upcoming July 29, 2026 results announcement are combining to reinforce confidence in its operating execution. We’ll now look at how Integra’s history of earnings beats and upcoming...

Goldman Sachs recently initiated coverage of Crown Castle (CCI) after its move to become a pure-play US tower operator. The firm highlighted both near-term revenue pressures and potential longer-term support from mobile data trends and cost-cutting. See our latest analysis for Crown Castle. Crown Castle’s recent coverage reset comes after a challenging stretch, with the share price down 11.2% year to date and its 1 year total shareholder return declining 20.8%. This suggests investors are...

Innodata's share price has climbed sharply over the past few years, yet its current checks lean toward the stock looking expensive rather than like an obvious bargain. After such a strong run, the tension for investors is between the powerful long term return profile and a low value score that points to limited margin of safety at today's levels. Over the last 5 years, Innodata has delivered a very large total return of about 8x, which sets a high bar for any further upside from...

Essex Property Trust has recently drawn attention as fresh research highlighted a gap between cash‑flow-based valuation models that imply potential undervaluation and earnings multiples that show the residential REIT trading at a premium to peers, ahead of its second‑quarter 2026 results released after July 29. Analyst interest has been reinforced by optimism about West Coast rental demand and Essex’s exposure to Bay Area economic activity tied to artificial intelligence, even as its...